1. 智能化融合:发展数据挖掘、集成、分析、可视化及人工智能工具,实现数据与文献、模型、计算等资源的有机融合,促进领域数智驱动科研新范式变革.
2. 标准化体系建设:以统一的数据标准管理体系为基础,系统整合全链条多源异构数据,聚焦高价值业务需求,精准构建结构合理、标注规范、语义清晰的数据资源.
3. 开放共享生态:开展数据提供方、使用方和服务方生态体系建设,实现多元主体间数据共享、共用、共治。.
4. 多模态数据处理:构建“全模态数据治理平台+高质量数据服务”一体化解决方案,提升非结构化数据处理能力.

Ozenoxacin, also known as GF-001001-00; M-5120; T-3912; GF-00100100, is an experimental quinolone antibiotic being developed for the treatment of impetigo and other dermatological bacterial infections...
Reference: Yu, Yang; Chen, Jingjin; Zhou, Huayin; Wang, Linyong; Zhang, Zhiqiang; Sun, Yuanjun; Qiu, Xin; Wang, Yuliang. Preparation method of intermediate of ozenoxacin antibacterial drug by Suzuki coupling reaction, and ozenoxacin from the intermediate. CN 108299480. (Assignee Shandong Bestcomm Pharmaceutical Co., Ltd., Peop. Rep. China)
Ceftobiprole medocaril (BAL5788) is a fifth-generation cephalosporin prodrug that exhibits potent in vitro and in vivo antimicrobial activity against a broad spectrum of Gram-positive and Gram-negativ...
Patent#: WO2010136423
Sparsentan, also known as RE-021, PS433540 and DARA-a, is a dual angiotensin II and endothelin A receptor antagonist. Sparsentan has demonstrated potent antagonism of ETA and AT1 receptors with Ki va...
Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2'-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and PharmacokineticsBy: Murugesan, Natesan; et alJournal of Medicinal Chemistry (2005), 48(1), 171-179
Aerobactin is a bacterial iron chelating agent (siderophore) found in E. coli. It is a virulence factor enabling E. coli to sequester iron in iron-poor environments such as the urinary tract. Aerobact...
1.1Catalysts:Copper sulfate;30 min, rt1.24 d, rt2.1Reagents:Sodium bicarbonateSolvents:Water;overnight, rt3.1Reagents:Thionyl chlorideSolvents:Ethanol;0 °C; 2 h, 0 °C; 0 °C → rt; overnight, rt4.1Solvents:Dichloromethane,Water;2 h, pH 10, 0 °C; 4 h, rt5.1Reagents:PyridineSolvents:Dichloromethane;4 h, 50 °C6.1Reagents:Hydrogen bromideSolvents:Acetic acid,Dichloromethane;40 min, rt7.1Reagents:Dicyclohexylcarbodiimide,N-HydroxysuccinimideSolvents:Tetrahydrofuran;30 min, rt7.2Solvents:Water;10 min, rt7.3Reagents:Sodium bicarbonateSolvents:Tetrahydrofuran;overnight, rt8.1Reagents:Trifluoroacetic acidSolvents:Dichloromethane;1 h, rt8.2Reagents:Sodium hydroxideSolvents:Tetrahydrofuran,Water;40 min, rt8.3Reagents:Hydrochloric acidSolvents:Water;pH 2, rt
Nirmatrelvir (PF-07321332) is a potent, selective, orally active inhibitor of the SARS-CoV-2 3CL protease (Mpro). In preclinical enzymatic assays, it inhibited Mpro with a Ki of ~3 nM and showed high ...
Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main ProteaseBy: Ngo, Chau; et alJournal of Medicinal Chemistry (2023), 66(17), 12237-12248
Suzetrigine, also known as VX-548, is a selective inhibitor of the voltage-gated sodium channel Nav1.7, being developed by Vertex Pharmaceuticals for the treatment of acute and neuropathic pain. It ex...
State-dependent inhibition of Nav1.8 sodium channels by VX-150 and VX-548By: Vaelli, Patric; et alMolecular Pharmacology (2024), 106(6), 298-308
Alcudacigib (ASP1570) is a small-molecule inhibitor of diacylglycerol kinase (DGK) developed to modulate tumor immunosuppression. In preclinical studies, it inhibited DGK activity in vitro and restore...
Preparation of pyridazinyl-thiazolecarboxamide compound as DGKζ inhibitorAssignees: Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.Inventors: Watanabe, Hideyuki; et alWorld Intellectual Property OrganizationPatent#WO2021132422 A1
Etravirine, also known as TMC 125 and R 165335, is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It was also approved in 2008. Etraviri...
Process for the preparation of 4- [6-amino-5-bromo-2- [(4-cyanophenyl) amino]-4-pyrimidinyl]oxy]-3.5-dimethylbe nzonitrile (Etravirine); Rajan, Srinivasan Thirumalai; Eswaraiah, Sajja; Gutta, Madhusudhan; Peri, Seetha Rama Sarma; Assignee MSN Laboratories Private Limited, India; 2016; Patent Information; Apr 21, 2016; WO 2016059646 A2
Zongertinib (BI 1810631) is an irreversible, oral HER2-selective tyrosine kinase inhibitor that demonstrates potent preclinical efficacy in HER2-driven cancers. It effectively inhibits tumor growth in...
Patent#: WO2021213800
Ticagrelor, also known as AZD-6140 and AR-C 126532XX, is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved in 2011. Ticagrelor is an antagonist of the P2Y12 receptor. Lik...
Zhang, Hao; Liu, Jun; Zhang, Luyong; Kong, Lingyi; Yao, Hequan; Sun, Hongbin. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. Volume 22. Issue 11. Pages 3598-3602. Journal; Online Computer File. (2012).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
